The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies

Journal of Anatomy

Volumn 224, Issue 1, 2014, Pages 36-44

  Fewou, Simon N ^a   Plomp, Jaap J ^b   Willison, Hugh J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoantibody; Ganglioside; Motor nerve terminal; Neuropathy

Indexed keywords

ACETYL COENZYME A; ACETYLCHOLINE; ADAPTOR PROTEIN; AUTOANTIBODY; BOTULINUM TOXIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE; CLATHRIN; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LECTIN; MEMBRANE ANTIGEN; NERVE GROWTH FACTOR; POTASSIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL;

ANTIBODY BLOOD LEVEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY MEDIATED NEUROTOXICITY; ANTIGEN BINDING; AUTOIMMUNE DISEASE; AUTOIMMUNE NEUROPATHY; AUTOIMMUNE SYNAPTOPATHY; BINDING SITE; CALCIUM TRANSPORT; ENDOCYTOSIS; EXOCYTOSIS; INTERNALIZATION; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; PERIPHERAL NEUROPATHY; POTASSIUM CURRENT; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RETROGRADE NERVE FIBER TRANSPORT; REVIEW; SYNAPSE VESICLE;

AUTOANTIBODY; GANGLIOSIDE; MOTOR NERVE TERMINAL; NEUROPATHY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; GANGLIOSIDES; HUMANS; MOTOR NEURONS; NEUROMUSCULAR JUNCTION DISEASES; NEUROTOXICITY SYNDROMES; PRESYNAPTIC TERMINALS;

EID: 84890176367     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/joa.12088     Document Type: Review

References (96)

1. Ando S (1983) Gangliosides in the nervous system. Neurochem Int 5, 507-537.
2. Ando S, Tanaka Y, Waki H, et al. (1998) Gangliosides and sialylcholesterol as modulators of synaptic functions. Ann N Y Acad Sci, 845, 232-239.
3. Ando S, Tanaka Y, Kobayashi S, et al. (2004) Synaptic function of cholinergic-specific Chol-1alpha ganglioside. Neurochem Res 29, 857-867.
4. Antonucci F, Rossi C, Gianfranceschi L, et al. (2008) Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28, 3689-3696.
5. Appel SH, Smith RG, Engelhardt JI, et al. (1993) Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 118, 169-174.
6. Arimura K, Watanabe O (2010) Immune-mediated neuromyotonia (Isaacs' syndrome) - clinical aspects and pathomechanism. Brain Nerve 62, 401-410.
7. Bowen S, Ateh DD, Deinhardt K, et al. (2007) The phagocytic capacity of neurones. Eur J Neurosci 25, 2947-2955.
8. Buchwald B, Weishaupt A, Toyka KV, et al. (1998) Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur J Neurosci 10, 281-290.
9. Bullens RW, O'Hanlon GM, Wagner E, et al. (2002) Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci 22, 6876-6884.
10. Caleo M, Antonucci F, Restani L, et al. (2009) A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism? J Neurochem 109, 15-24.
11. Chamberlain LH, Burgoyne RD, Gould GW (2001) SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc Natl Acad Sci U S A 98, 5619-5624.
12. Clayton EL, Cousin MA (2009) The molecular physiology of activity-dependent bulk endocytosis of synaptic vesicles. J Neurochem 111, 901-914.
13. Davies A, Douglas L, Hendrich J, et al. (2006) The calcium channel alpha2delta-2 subunit partitions with CaV2.1 into lipid rafts in cerebellum: implications for localization and function. J Neurosci 26, 8748-8757.
14. Deinhardt K, Reversi A, Berninghausen O, et al. (2007) Neurotrophins redirect p75NTR from a clathrin-independent to a clathrin-dependent endocytic pathway coupled to axonal transport. Traffic 8, 1736-1749.
15. Diefenbach RJ, Miranda-Saksena M, Douglas MW, et al. (2008) Transport and egress of herpes simplex virus in neurons. Rev Med Virol 18, 35-51.
16. Dittman J, Ryan TA (2009) Molecular circuitry of endocytosis at nerve terminals. Annu Rev Cell Dev Biol 25, 133-160.
17. van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 7, 939-950.
18. Egorushkina NV, Ratushnyak AS, Egorushkin IV (1993) The influence of exogenous gangliosides on the dynamics of the development of prolonged posttetanic potentiation. Neurosci Behav Physiol 23, 435-438.
19. Engelhardt J, Joo F (1986) An immune-mediated guinea pig model for lower motor neuron disease. J Neuroimmunol 12, 279-290.
20. Fabian RH (1990) Uptake of antineuronal IgM by CNS neurons: comparison with antineuronal IgG. Neurology 40(3 Pt 1), 419-422.
21. Fewou SN, Rupp A, Nickolay LE, et al. (2012) Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J Clin Invest 122, 1037-1051.
22. Fischer von MG, Stahl B, Walch-Solimena C, et al. (1994) Localization of Rab5 to synaptic vesicles identifies endosomal intermediate in synaptic vesicle recycling pathway. Eur J Cell Biol 65, 319-326.
23. Fujii S, Igarashi K, Sasaki H, et al. (2002) Effects of the mono- and tetrasialogangliosides GM1 and GQ1b on ATP-induced long-term potentiation in hippocampal CA1 neurons. Glycobiology 12, 339-344.
24. Fujita A, Cheng J, Hirakawa M, et al. (2007) Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling. Mol Biol Cell 18, 2112-2122.
25. Furuse H, Waki H, Kaneko K, et al. (1998) Effect of the mono- and tetra-sialogangliosides, GM1 and GQ1b, on long-term potentiation in the CA1 hippocampal neurons of the guinea pig. Exp Brain Res 123, 307-314.
26. Gonzalez LE, Kotler ML, Vattino LG, et al. (2011) Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels. J Neurochem 119, 826-838.
27. van der Goot FG, Harder T (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13, 89-97.
28. Granseth B, Odermatt B, Royle SJ, et al. (2007) Clathrin-mediated endocytosis: the physiological mechanism of vesicle retrieval at hippocampal synapses. J Physiol 585(Pt 3), 681-686.
29. Hanzal-Bayer MF, Hancock JF (2007) Lipid rafts and membrane traffic. FEBS Lett 581, 2098-2104.
30. He L, Wu LG (2007) The debate on the kiss-and-run fusion at synapses. Trends Neurosci 30, 447-455.
31. Henaff D, Salinas S (2010) An endocytic CARriage tale: Adenoviruses internalization and trafficking in neurons. Virulence 1, 188-191.
32. Hirsch NP (2007) Neuromuscular junction in health and disease. Br J Anaesth 99, 132-138.
33. Ho TW, Hsieh ST, Nachamkin I, et al. (1997) Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48, 717-724.
34. Iglesias-Bartolome R, Crespo PM, Gomez GA, et al. (2006) The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin. FEBS J 273, 1744-1758.
35. Inoue M, Fujii Y, Furukawa K, et al. (2002) Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem 277, 29881-29888.
36. Jennemann R, Sandhoff R, Wang S, et al. (2005) Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci U S A 102, 12459-12464.
37. Jockusch WJ, Praefcke GJ, McMahon HT, et al. (2005) Clathrin-dependent and clathrin-independent retrieval of synaptic vesicles in retinal bipolar cells. Neuron 46, 869-878.
38. Jung N, Haucke V (2007) Clathrin-mediated endocytosis at synapses. Traffic 8, 1129-1136.
39. Kasahara K, Watanabe K, Takeuchi K, et al. (2000) Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts. J Biol Chem 275, 34701-34709.
40. Kawai H, Allende ML, Wada R, et al. (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276, 6885-6888.
41. Kobayashi S, Yokoyama S, Maruta T, et al. (2013) Autoantibody-induced internalization of nicotinic acetylcholine receptor alpha3 subunit exogenously expressed in human embryonic kidney cells. J Neuroimmunol 257, 102-106.
42. Kuwabara S, Misawa S, Takahashi H, et al. (2007) Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle. J Neuroimmunol 189, 158-162.
43. Lalli G, Bohnert S, Deinhardt K, et al. (2003) The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol 11, 431-437.
44. Lancaster E, Huijbers MG, Bar V, et al. (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69, 303-311.
45. Lang T, Bruns D, Wenzel D, et al. (2001) SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J 20, 2202-2213.
46. Ledeen RW (1985) Gangliosides of the neuron. Trends Neurosci 8, 169-174.
47. Ledeen RW, Wu G (2006) GM1 ganglioside: another nuclear lipid that modulates nuclear calcium. GM1 potentiates the nuclear sodium-calcium exchanger. Can J Physiol Pharmacol, 84, 393-402.
48. Lloyd KO, Furukawa K (1998) Biosynthesis and functions of gangliosides: recent advances. Glycoconj J 15, 627-636.
49. Maccioni HJ (2007) Glycosylation of glycolipids in the Golgi complex. J Neurochem 103(Suppl 1), 81-90.
50. Martin PT (2003) Glycobiology of the neuromuscular junction. J Neurocytol 32, 915-929.
51. Mizisin AP, Weerasuriya A (2011) Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol 121, 291-312.
52. O'Hanlon GM, Plomp JJ, Chakrabarti M, et al. (2001) Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124(Pt 5), 893-906.
53. O'Hanlon GM, Bullens RW, Plomp JJ, et al. (2002) Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochem Res 27, 697-709.
54. O'Hanlon GM, Humphreys PD, Goldman RS, et al. (2003) Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain 126(Pt 11), 2497-2509.
55. Ohka S, Sakai M, Bohnert S, et al. (2009) Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J Virol 83, 4995-5004.
56. Okada M, Itoh MM, Haraguchi M, et al. (2002) b-Series ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277, 1633-1636.
57. Pagani MR, Gonzalez LE, Uchitel OD (2011) Autoimmunity in amyotrophic lateral sclerosis: past and present. Neurol Res Int, 2011, 497080.
58. Pike LJ (2006) Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47, 1597-1598.
59. Plomp JJ, Willison HJ (2009) Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 587(Pt 16), 3979-3999.
60. Plomp JJ, Molenaar PC, O'Hanlon GM, et al. (1999) Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 45, 189-199.
61. Prinetti A, Prioni S, Chigorno V, et al. (2001) Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by anti-GD3 ganglioside monoclonal antibody. J Neurochem 78, 1162-1167.
62. Rahmann H, Schifferer F, Beitinger H (1992) Calcium-ganglioside interactions and synaptic plasticity: effect of calcium on specific ganglioside/peptide (valinomycin, gramicidin A)-complexes in mixed mono- and bilayers. Neurochem Int 20, 323-338.
63. Ramirez OA, Gomez RA, Carrer HF (1990) Gangliosides improve synaptic transmission in dentate gyrus of hippocampal rat slices. Brain Res 506, 291-293.
64. Rink J, Ghigo E, Kalaidzidis Y, et al. (2005) Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735-749.
65. Ritchie TC, Fabian RH, Coulter JD (1985) Axonal transport of antibodies to subcellular and protein fractions of rat brain. Brain Res 343, 252-261.
66. Rizzoli SO, Jahn R (2007) Kiss-and-run, collapse and 'readily retrievable' vesicles. Traffic 8, 1137-1144.
67. Salaun C, James DJ, Chamberlain LH (2004) Lipid rafts and the regulation of exocytosis. Traffic 5, 255-264.
68. Salinas S, Bilsland LG, Henaff D, et al. (2009) CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog, 5, e1000442.
69. Salinas S, Schiavo G, Kremer EJ (2010) A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol 8, 645-655.
70. Schroer TA (2004) Dynactin. Annu Rev Cell Dev Biol 20, 759-779.
71. Sheikh KA, Sun J, Liu Y, et al. (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96, 7532-7537.
72. Shlosberg D, Benifla M, Kaufer D, et al. (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6, 393-403.
73. Silveira e Souza AM, Mazucato VM, de Castro RO, et al. (2008) The alpha-galactosyl derivatives of ganglioside GD(1b) are essential for the organization of lipid rafts in RBL-2H3 mast cells. Exp Cell Res, 314, 2515-2528.
74. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387, 569-572.
75. Slater CR (2008) Structural factors influencing the efficacy of neuromuscular transmission. Ann N Y Acad Sci, 1132, 1-12.
76. Smith RG, Engelhardt JI, Tajti J, et al. (1993) Experimental immune-mediated motor neuron diseases: models for human ALS. Brain Res Bull 30, 373-380.
77. Sonnino S, Mauri L, Chigorno V, et al. (2007) Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R-13R.
78. Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27, 509-547.
79. Sugiura Y, Furukawa K, Tajima O, et al. (2005) Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience 135, 1167-1178.
80. Susuki K, Baba H, Tohyama K, et al. (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55, 746-757.
81. Svennerholm L (1994) Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res, 101, XI-XIV.
82. 2+ influx and acetylcholine release in brain synaptosomes. NeuroReport 8, 2203-2207.
83. Taverna E, Saba E, Rowe J, et al. (2004) Role of lipid microdomains in P/Q-type calcium channel (Cav2.1) clustering and function in presynaptic membranes. J Biol Chem 279, 5127-5134.
84. Thomas PD, Brewer GJ (1990) Gangliosides and synaptic transmission. Biochim Biophys Acta 1031, 277-289.
85. Titulaer MJ, Verschuuren JJ (2008) Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms. Ann N Y Acad Sci, 1132, 129-134.
86. Tsukita S, Ishikawa H (1980) The movement of membranous organelles in axons. Electron microscopic identification of anterogradely and retrogradely transported organelles. J Cell Biol 84, 513-530.
87. Voglmaier SM, Edwards RH (2007) Do different endocytic pathways make different synaptic vesicles? Curr Opin Neurobiol 17, 374-380.
88. Vonderheit A, Helenius A (2005) Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol 3, e233.
89. Vyas KA, Patel HV, Vyas AA, et al. (2001) Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol Chem 382, 241-250.
90. Weerasuriya A, Mizisin AP (2011) The blood-nerve barrier: structure and functional significance. Methods Mol Biol 686, 149-173.
91. Wieraszko A, Seifert W (1985) The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices. Brain Res 345, 159-164.
92. Wu G, Ledeen RW (1994) Gangliosides as modulators of neuronal calcium. Prog Brain Res 101, 101-112.
93. Wucherpfennig T, Wilsch-Brauninger M, Gonzalez-Gaitan M (2003) Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release. J Cell Biol 161, 609-624.
94. Yuki N, Koga M (2006) Bacterial infections in Guillain-Barre and Fisher syndromes. Curr Opin Neurol 19, 451-457.
95. Zitman FM, Todorov B, Jacobs BC, et al. (2008) Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience 156, 885-897.
96. Zitman FM, Todorov B, Verschuuren JJ, et al. (2011) Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol Aging 32, 157-167.